Gilead Sciences, Inc. (GILD:NASDAQ)

Last update - 28 October 2022 By Rivkin

Gilead Sciences Inc. (GILD) posted revenue of $7.42 billion beating estimates of by $922 million, with an EPS of $1.88.

We are glad you are enjoying our content and we’d like to help you achieving your financial goals.

This content is only for Rivkin Report Members.

Start a free 14-day trial to access this article and:

  • 6 Model Portfolios for Income and Growth

  • In-Depth Stock Analysis: identify potential investment opportunities

  • Q&A sessions with our CIO, Shannon Rivkin

Be the first to know. Get the Morning Market Wrap each morning.